Cystatin C promotes cognitive dysfunction in rats with cerebral microbleeds by inhibiting the ERK/synapsin Ia/Ib pathway

  • Authors:
    • Guangna Yu
    • Xingyuan Sun
    • Li Li
    • Lijuan Huang
    • Hongbin Liu
    • Shuying Wang
    • Zhanjun Ren
    • Yanjiao Zhang
  • View Affiliations

  • Published online on: December 31, 2019     https://doi.org/10.3892/etm.2019.8403
  • Pages: 2282-2290
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Although higher serum level of cystatin C (CysC) was observed in patients with cerebral microbleeds, its associated role in the disease has not been elucidated. In this work, a rat model of cerebral microbleeds was created with the aim of investigating effects of CysC on cognitive function in rats with cerebral microbleeds and the underlying mechanism. Serum samples of patients with cerebral microbleeds and healthy people of the same age were collected. Levels of cystatin C expression in these samples were measured using CysC kits. Moreover, 48 spontaneously hypertensive rats (SHRs) bred under specific pathogen‑free (SPF) conditions were randomly divided into 4 groups: sham surgery control group (sham), model group (CMB), model + empty vector control group (CMB + vehicle), and model + cystatin C overexpression group (CMB + CysC). Expression levels of CysC in hippocampus of rats in each group were measured by western blot analysis. The Y‑maze was used to evaluate cognitive function of rats. Hippocampal long‑term potentiation (LTP) in rats was assessed by the electrophysiological assay. Alterations in levels of p‑ERK1/2 and p‑synapsin Ia/b proteins associated with cognitive function were identified by western blot analysis. The serum levels of CysC in patients with cerebral microbleeds were significantly upregulated (P<0.001). After injection of CysC, its expression levels in rat hippocampus were significantly increased (P<0.001), which enhanced the decline in learning and memory function, as well as the decrease of LTP in the rat model of cerebral microbleeds (P<0.001). Western blot results showed that injection of CysC further reduced the levels of p‑ERK1/2 and p‑synapsin Ia/b in the rat model of microbleeds (P<0.001). CysC was up regulated in serum of patients with cerebral microbleeds. It promoted cognitive dysfunction in rats with microbleeds by inhibiting ERK/synapsin Ia/Ib pathway.
View Figures
View References

Related Articles

Journal Cover

March 2020
Volume 19 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Yu, G., Sun, X., Li, L., Huang, L., Liu, H., Wang, S. ... Zhang, Y. (2020). Cystatin C promotes cognitive dysfunction in rats with cerebral microbleeds by inhibiting the ERK/synapsin Ia/Ib pathway. Experimental and Therapeutic Medicine, 19, 2282-2290. https://doi.org/10.3892/etm.2019.8403
MLA
Yu, G., Sun, X., Li, L., Huang, L., Liu, H., Wang, S., Ren, Z., Zhang, Y."Cystatin C promotes cognitive dysfunction in rats with cerebral microbleeds by inhibiting the ERK/synapsin Ia/Ib pathway". Experimental and Therapeutic Medicine 19.3 (2020): 2282-2290.
Chicago
Yu, G., Sun, X., Li, L., Huang, L., Liu, H., Wang, S., Ren, Z., Zhang, Y."Cystatin C promotes cognitive dysfunction in rats with cerebral microbleeds by inhibiting the ERK/synapsin Ia/Ib pathway". Experimental and Therapeutic Medicine 19, no. 3 (2020): 2282-2290. https://doi.org/10.3892/etm.2019.8403